coptisine has been researched along with camptothecin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; Shao, L; Wang, S; Zhang, H | 1 |
| Fujinami, D; Hanada, K; Inoue, N; Ishizaki, T; Kawano, M; Kohda, D; Matsuoka, S; Narahara, H; Nishida, Y; Takiguchi-Kawashima, Y; Tanaka, K; Terabayashi, T; Tsumura, H | 1 |
2 other study(ies) available for coptisine and camptothecin
| Article | Year |
|---|---|
CHMIS-C: a comprehensive herbal medicine information system for cancer.
Topics: Antineoplastic Agents, Phytogenic; Databases, Factual; Internet; National Institutes of Health (U.S.); Neoplasms; Phytotherapy; Plant Preparations; United States; United States Food and Drug Administration | 2005 |
The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Camptothecin; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Replication; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Herbal Medicine; Humans; Topoisomerase I Inhibitors | 2021 |